Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab

J Eur Acad Dermatol Venereol. 2017 Aug;31(8):e350-e351. doi: 10.1111/jdv.14144. Epub 2017 Feb 20.

Authors

K C Wei¹, Y H Wang^{1

2}, W H Wang², W Chen^{3

4}

Affiliations

¹ Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
² Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
³ IZZ-Immunologie Zentrum Zürich, Zurich, Switzerland.
⁴ Department of Dermatology and Allergy, Technische Universität München, Munich, Germany.

PMID: 28129481
DOI: 10.1111/jdv.14144

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Fatal Outcome
Humans
Immunologic Factors / adverse effects*
Immunologic Factors / therapeutic use
Male
Middle Aged
Pemphigus / drug therapy
Pneumocystis carinii*
Pneumonia, Pneumocystis / chemically induced*
Rituximab / adverse effects*
Rituximab / therapeutic use

Substances

Immunologic Factors
Rituximab